BD Gene Therapeutics

About:

BD Gene Therapeutics is a provider of a gene-editing platform for the treatment of genetic diseases.

Website: https://bdgenetherapeutics.com

Top Investors: Sunland Fund, Keytone Ventures, Longpan Investment, Tongde Capital, Penglai Capital

Description:

BD Gene Therapeutics is a provider of a gene-editing platform for the treatment of genetic diseases. It uses mRNA delivery technology to achieve safe and efficient delivery of gene-editing tools such as CRISPR. In addition, BD-mRNA technology has important application prospects in the fields of tumor immunity and regenerative medicine. It also uses the fourth-generation lentiviral vector platform for all types of cells. It has developed antiviral eyedrops and others.

Total Funding Amount:

210M CNY

Headquarters Location:

Minhang, Shanghai, China

Founded Date:

2018-07-31

Contact Email:

ting.xu(AT)bdgene.cn

Founders:

Yujia Cai

Number of Employees:

11-50

Last Funding Date:

2023-06-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai